82 related articles for article (PubMed ID: 20722702)
1. Depth of response assessed by quantitative ASO-PCR predicts the outcome after stem cell transplantation in multiple myeloma.
Putkonen M; Kairisto V; Juvonen V; Pelliniemi TT; Rauhala A; Itälä-Remes M; Remes K
Eur J Haematol; 2010 Nov; 85(5):416-23. PubMed ID: 20722702
[TBL] [Abstract][Full Text] [Related]
2. [Minimal residual disease assessment and progress in multiple myeloma].
Zhou HX; Chen WM
Zhonghua Xue Ye Xue Za Zhi; 2024 Feb; 45(2):203-208. PubMed ID: 38604801
[TBL] [Abstract][Full Text] [Related]
3. Measurable residual disease in multiple myeloma: ready for clinical practice?
Burgos L; Puig N; Cedena MT; Mateos MV; Lahuerta JJ; Paiva B; San-Miguel JF
J Hematol Oncol; 2020 Jun; 13(1):82. PubMed ID: 32571377
[TBL] [Abstract][Full Text] [Related]
4. Minimal Residual Disease Assessment in the Context of Multiple Myeloma Treatment.
Nishihori T; Song J; Shain KH
Curr Hematol Malig Rep; 2016 Apr; 11(2):118-26. PubMed ID: 26898557
[TBL] [Abstract][Full Text] [Related]
5. MRD negativity: considerations for older adults with multiple myeloma.
Mian H; Wildes TM; Venner CP; Fonseca R
Blood Cancer J; 2023 Nov; 13(1):166. PubMed ID: 37938551
[No Abstract] [Full Text] [Related]
6. Treatment With Carfilzomib-Lenalidomide-Dexamethasone With Lenalidomide Extension in Patients With Smoldering or Newly Diagnosed Multiple Myeloma.
Korde N; Roschewski M; Zingone A; Kwok M; Manasanch EE; Bhutani M; Tageja N; Kazandjian D; Mailankody S; Wu P; Morrison C; Costello R; Zhang Y; Burton D; Mulquin M; Zuchlinski D; Lamping L; Carpenter A; Wall Y; Carter G; Cunningham SC; Gounden V; Sissung TM; Peer C; Maric I; Calvo KR; Braylan R; Yuan C; Stetler-Stevenson M; Arthur DC; Kong KA; Weng L; Faham M; Lindenberg L; Kurdziel K; Choyke P; Steinberg SM; Figg W; Landgren O
JAMA Oncol; 2015 Sep; 1(6):746-54. PubMed ID: 26181891
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of deep sequencing method for minimal residual disease detection in multiple myeloma.
Martinez-Lopez J; Lahuerta JJ; Pepin F; González M; Barrio S; Ayala R; Puig N; Montalban MA; Paiva B; Weng L; Jiménez C; Sopena M; Moorhead M; Cedena T; Rapado I; Mateos MV; Rosiñol L; Oriol A; Blanchard MJ; Martínez R; Bladé J; San Miguel J; Faham M; García-Sanz R
Blood; 2014 May; 123(20):3073-9. PubMed ID: 24646471
[TBL] [Abstract][Full Text] [Related]
8. Next-generation sequencing and real-time quantitative PCR for minimal residual disease detection in B-cell disorders.
Ladetto M; Brüggemann M; Monitillo L; Ferrero S; Pepin F; Drandi D; Barbero D; Palumbo A; Passera R; Boccadoro M; Ritgen M; Gökbuget N; Zheng J; Carlton V; Trautmann H; Faham M; Pott C
Leukemia; 2014 Jun; 28(6):1299-307. PubMed ID: 24342950
[TBL] [Abstract][Full Text] [Related]
9. Minimal residual disease assessed by multiparameter flow cytometry in multiple myeloma: impact on outcome in the Medical Research Council Myeloma IX Study.
Rawstron AC; Child JA; de Tute RM; Davies FE; Gregory WM; Bell SE; Szubert AJ; Navarro-Coy N; Drayson MT; Feyler S; Ross FM; Cook G; Jackson GH; Morgan GJ; Owen RG
J Clin Oncol; 2013 Jul; 31(20):2540-7. PubMed ID: 23733781
[TBL] [Abstract][Full Text] [Related]
10. Minimal Residual Disease in Multiple Myeloma: Something Old, Something New.
Bravo-Pérez C; Sola M; Teruel-Montoya R; García-Malo MD; Ortuño FJ; Vicente V; de Arriba F; Jerez A
Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503142
[TBL] [Abstract][Full Text] [Related]
11. A large meta-analysis establishes the role of MRD negativity in long-term survival outcomes in patients with multiple myeloma.
Munshi NC; Avet-Loiseau H; Anderson KC; Neri P; Paiva B; Samur M; Dimopoulos M; Kulakova M; Lam A; Hashim M; He J; Heeg B; Ukropec J; Vermeulen J; Cote S; Bahlis N
Blood Adv; 2020 Dec; 4(23):5988-5999. PubMed ID: 33284948
[TBL] [Abstract][Full Text] [Related]
12. Minimal Residual Disease in Multiple Myeloma: Current Landscape and Future Applications With Immunotherapeutic Approaches.
Kostopoulos IV; Ntanasis-Stathopoulos I; Gavriatopoulou M; Tsitsilonis OE; Terpos E
Front Oncol; 2020; 10():860. PubMed ID: 32537439
[TBL] [Abstract][Full Text] [Related]
13. Minimal Residual Disease Assessment Within the Bone Marrow of Multiple Myeloma: A Review of Caveats, Clinical Significance and Future Perspectives.
Romano A; Palumbo GA; Parrinello NL; Conticello C; Martello M; Terragna C
Front Oncol; 2019; 9():699. PubMed ID: 31482061
[TBL] [Abstract][Full Text] [Related]
14. Minimal Residual Disease Monitoring with Next-Generation Sequencing Methodologies in Hematological Malignancies.
Sánchez R; Ayala R; Martínez-López J
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31185671
[TBL] [Abstract][Full Text] [Related]
15. Current role of high dose chemotherapy in the management of multiple myeloma.
Gertz MA
Leuk Lymphoma; 2019 Jun; 60(6):1349-1351. PubMed ID: 30526195
[No Abstract] [Full Text] [Related]
16. BMT CTN Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling: Summary and Recommendations from the Organizing Committee.
Holstein SA; Avet-Loiseau H; Hahn T; Ho CM; Lohr JG; Munshi NC; Paiva B; Pasquini MC; Tario JD; Usmani SZ; Wallace PK; Weisel K; McCarthy PL
Biol Blood Marrow Transplant; 2018 Apr; 24(4):641-648. PubMed ID: 29242112
[TBL] [Abstract][Full Text] [Related]
17. Minimal residual disease analysis in myeloma - when, why and where.
Yanamandra U; Kumar SK
Leuk Lymphoma; 2018 Aug; 59(8):1772-1784. PubMed ID: 29019452
[TBL] [Abstract][Full Text] [Related]
18. Minimal residual disease testing after stem cell transplantation for multiple myeloma.
Sherrod AM; Hari P; Mosse CA; Walker RC; Cornell RF
Bone Marrow Transplant; 2016 Jan; 51(1):2-12. PubMed ID: 26191950
[TBL] [Abstract][Full Text] [Related]
19. New criteria for response assessment: role of minimal residual disease in multiple myeloma.
Paiva B; van Dongen JJ; Orfao A
Blood; 2015 May; 125(20):3059-68. PubMed ID: 25838346
[TBL] [Abstract][Full Text] [Related]
20. Consolidation in multiple myeloma - current status and perspectives.
Olszewska-Szopa M; Rzepecki P
Contemp Oncol (Pozn); 2014; 18(5):313-7. PubMed ID: 25477752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
